Tenex Health

Tenex Health, founded in 2009 and acquired by Trice Medical in 2021, is a commercial-stage medical device company focused on minimally invasive solutions for chronic musculoskeletal pain. Its core technology is the Tenex Health TX System, an ultrasonic platform developed in collaboration with the Mayo Clinic to perform percutaneous tenotomy and remove calcifications and bone spurs. With over 240,000 procedures performed and strong clinical data showing high patient satisfaction, the company targets a large market of patients who have failed conservative treatments but wish to avoid traditional surgery. The recent launch of its 2nd Generation System aims to expand capabilities and procedural efficiency.

Minimally invasive ultrasonic technology platform for percutaneous debridement of diseased tendon tissue, calcifications, and bone spurs. The Tenex Health TX System uses high-frequency ultrasonic energy delivered via a small probe under local anesthesia.

Tenex competes in the minimally invasive musculoskeletal treatment space against other percutaneous needle tenotomy devices, extracorporeal shockwave therapy (ESWT), and advanced injection therapies (e.g., platelet-rich plasma, stem cells). Its key differentiator is the direct removal of pathological tissue under ultrasonic guidance, supported by a strong volume of clinical literature and procedural history.